Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.1.108 (
TAT
)
2,389
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A generalized deficiency of the mitochondrial matrix enzyme
ornithine aminotransferase
(
OAT
) is the inborn error in
gyrate atrophy
(GA), an autosomal recessive degenerative disease of the retina and choroid of the eye. Mutations in the
OAT
gene show a high degree of molecular heterogeneity in GA, reflecting the genetic heterogeneity in this disease. Using the combined techniques of PCR, denaturing gradient gel electrophoresis, and direct sequencing, we have identified three nonsense-codon mutations and one nonsense codon-generating mutation of the
OAT
gene in GA pedigrees. Three of them are single-base substitutions, and one is a 2-bp deletion resulting in a reading frameshift. A nonsense codon created at position 79 (TGA) by a frameshift and nonsense mutations at codons 209 (
TAT
----TAA) and 299 (TAC----TAG) result in abnormally low levels of
OAT
mRNA in the patient's skin fibroblasts. A nonsense mutation at codon 426 (CGA----TGA) in the last exon, however, has little effect on the mRNA level. Thus, the mRNA level can be reduced by nonsense-codon mutations, but the position of the mutation may be important, with earlier premature-translation termination having a greater effect than a later mutation.
...
PMID:Nonsense-codon mutations of the ornithine aminotransferase gene with decreased levels of mutant mRNA in gyrate atrophy. 160 8
A generalized deficiency of the mitochondrial enzyme,
ornithine aminotransferase
(
OAT
) is the inborn error in
gyrate atrophy
, an autosomal recessive degenerative disease of the choroid and retina of the eye that leads to blindness. Southern analysis, using the
OAT
cDNA probe, of the
OAT
gene in a
gyrate atrophy
patient whose level of
OAT
protein is markedly decreased indicated the functional gene to be grossly intact. Northern analysis of his
OAT
mRNA demonstrated only half the normal level of
OAT
message, suggesting expression of only one of the two alleles of the
OAT
gene. A functional assay of the expressed
OAT
mRNA by in vitro translation and immunoprecipitation with anti-human
OAT
antibody indicated synthesis of an
OAT
protein from the message. The expressed message was cloned and sequenced and was shown to contain a single base change from C to T, resulting in an amino acid codon change from CAT (histidine) to
TAT
(tyrosine) at position 319 in the translated
OAT
protein. The mutant and normal
OAT
precursors were synthesized using transcriptional expression clones of
OAT
and in vitro translation of the expressed mRNA and tested in an in vitro mitochondrial transport/processing system. The results indicate that the mutant
OAT
precursor from the
gyrate atrophy
patient can be transported to the mitochondria but is minimally processed there, which would lead to degradation of the labile precursor and loss of
OAT
activity as phenotypically observed.
...
PMID:Point mutation affecting processing of the ornithine aminotransferase precursor protein in gyrate atrophy. 279 65